A pragmatic randomized controlled trial of a CKD specific telemonitoring platform to minimize adverse outcomes in high risk CKD patients.

  • Rigatto, Claudio C. (PI)
  • Bohm, Clara C. (CoPI)
  • Collister, David (CoPI)
  • Jain, Arsh Kumar A.K. (CoPI)
  • Komenda, Paul Vincent James P.V.J. (CoPI)
  • Levin, Adeera A. (CoPI)
  • Mackay, Dylan Stapenhorst (CoPI)
  • Macrae, Jennifer Marie J.M. (CoPI)
  • Pandeya, Sanjay S. (CoPI)
  • Pannu, Neesh Inder N.I. (CoPI)
  • Sood, Manish M M.M. (CoPI)
  • Suri, Rita (CoPI)
  • Tangri, Navdeep (CoPI)
  • Tennankore, Karthik Kannan (CoPI)
  • Zimmerman, Deborah Lynn D. (CoPI)

Project: Research project

Project Details

Description

The COVID-19 pandemic has changed the way patients with chronic kidney disease (CKD) are cared for in Canada. Since CKD patients are at high risk of getting very sick from COVID19, they are being cared for with "virtual visits", with telephone or video conference calls. While this helps prevent spread of the virus it makes taking care of kidney problems more difficult. CKD patients need careful monitoring of kidney function, blood pressure and weight; of how they feel; and they need education about their kidney disease, diet, and choices for dialysis or kidney transplant. Simple phone or video calls is not enough for proper care.. Additional home monitoring is needed to improve virtual care for CKD patients. We developed a home monitoring kit called VIEWER which is designed for CKD patients and includes an iPad, a blood pressure monitor, a weigh scale, a finger-tip oxygen monitor, and a motion tracker (like a FitBit). All of these devices talk wirelessly (by Bluetooth) to the iPad. The VIEWER app guides patients through a daily home assessment. The app helps patients do a symptom questionnaire once a week to monitor how they are feeling. Patients can see all their information, and can text, call, or video the health team through the iPad. The health care team can see all this information to help assess changes and to guide treatments. To test if VIEWER improves care, we will do a type of study called a randomized clinical trial (RCT). We will ask 340 patient volunteers with low kidney function (

StatusFinished
Effective start/end date3/1/212/28/24

Funding

  • Institute of Health Services and Policy Research: US$423,751.00

ASJC Scopus Subject Areas

  • Nephrology
  • Health Policy
  • Medicine (miscellaneous)